Therese (Tess) Woodring, MD, PGY 5, and fellow in the Division of Hematology, Oncology, Transplant, and Cellular Therapy, received a travel award to attend Primary Immune Deficiency Treatment Consortium (PIDTC) Education Day in St. Petersburg, Florida, March 10–11. The event is an opportunity to meet with leading immunologists, hematologists, rheumatologists, and transplanters who care for patients with inborn errors of immunity, immune dysregulation, and bone marrow failure. The award covers travel expenses for the two-day educational meeting as well as the PIDTC scientific meeting that follows. She will present her talk, “NOMID-like inflammatory disease and thrombotic microangiopathy (TMA) in an infant with NLRP3 variant of uncertain significance,” about a patient who presented to our intensive care unit with severe, unexplained inflammatory symptoms and experienced a complete response with a targeted agent.